Short answer
Dexcom (DXCM) filed its Q2 2025 10-Q quarterly report on Jul 30, 2025 for the quarter ended Jun 30, 2025. Quarterly revenue was $1.2B (up 15.2% year over year) with net income of $180M.
Q2 2025 key financials · XBRL
- Revenue
- $1.2B
- +15.2% YoY · +11.7% QoQ
- Net income
- $180M
- +25.3% YoY · +70.6% QoQ
- Operating margin
- 18.4%
- Gross margin
- 59.5%
- EPS (diluted)
- $0.44
- +25.7% YoY · +63.0% QoQ
Source: XBRL data from the Dexcom (DXCM) Q2 2025 10-Q on SEC EDGAR. USD.
Dexcom Q2 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $1.16B, up 15% YoY from $1.00B in Q2 2024, driven by disposable sensor volume growth
- Operating margin 18.4% vs 15.7% YoY, operating income $212.6M up 35% reflecting improved profitability
- Best segment: Disposable sensors ~97% of revenue, increased volume adding 500k-600k customers; worst: Reusable Hardware down to 3% from 6% of revenue
- Cash and equivalents $2.93B, operating cash flow $303M increased 8% YoY
- Near-term headwinds: Pricing pressure from rebates and channel mix, gross margin declined from 62.4% to 59.5% due to supply inefficiencies and product mix changes
Risk Factors
- No newly added risk factors this quarter; risk section supplements and supersedes 2024 10-K risks
- No material changes to previously disclosed risks; 10-K risk factors remain primary disclosures
- No updated regulatory, legal, or compliance risks specified beyond those in 2024 10-K
- No operational or market risk updates; previous supply chain and competition risks continue
- No new financial risks related to liquidity, debt, currency, or concentration reported this quarter
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Dexcom quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.